13 research outputs found
Coronal T2-weighted FLAIR images of a 45 year old woman with HSV encephalitis (Patient 3).
<p>On day 7 of admission a five-day course of corticosteroids was started. The same image slice is depicted from the day 2 scan (Image 1), from day 6 (Image 2) and from day 21 (Image 3)</p
Characteristics of the patients on admission and their outcomes up to one year post discharge.
<p>Characteristics of the patients on admission and their outcomes up to one year post discharge.</p
Image using the easymeasure stereology, point counting software showing the landmarks for temporal lobe measurements.
<p>(1) where the lateral ventricle splits into the temporal and frontal horns as the posterior limit for the right temporal lobe in a HSV encephalitis patient; (2) the mid point of the right temporal lobe measurement (in yellow the previously calculated left temporal lobe calculation); (3) the anterior limit of the temporal lobe and (4) the mid point section in (2) showing the volume of the overall damage including that outwith the temporal lobe, where HSV is seen to affect the right temporal lobe on this slice.</p
Flow chart of inclusion of patients in this study.
<p>Flow chart of inclusion of patients in this study.</p
A 2x2 table demonstrating whether volume changes increased or decreased in the two groups of patients, those treated with corticosteroids and those that were not.
<p>A 2x2 table demonstrating whether volume changes increased or decreased in the two groups of patients, those treated with corticosteroids and those that were not.</p
Details of the scan parameters for each patient.
<p>Details of the scan parameters for each patient.</p
Change in volume of total oedema over time.
<p>Patients 1 and 3 received corticosteroids during their care in hospital.</p
Change in volume of most affected temporal lobe over time.
<p>Patients 1 and 3 received corticosteroids during their care in hospital.</p
Frequency of mutant <i>TERT</i> promoter reads in urinary DNA.
<p>The graph shows the percentage of mutant reads in each patient sample considering point mutations at positions chr5:1295228, chr5:1295242/1295243 and chr:1295250.</p
Occurrence of cosmic listed point mutations in urinary DNA from UBC patients.
<p>Each column represents an individual patient. Oncoprint representation generated at <a href="http://www.cbioportal.org/" target="_blank">http://www.cbioportal.org/</a>.</p